Product Code: RP-ID-10151890 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151890
Market Overview:
Global Drug Infusion Systems Industry Market Research 2022-2030
"The drug infusion system is a medical device that allows the infusion of drugs such as antibiotics, chemotherapeutics, insulin, analgesics and other drugs in a controlled manner. The prevalence of chronic diseases such as cardiovascular disease, stroke, cancer, type 2 diabetes, and obesity has increased. And arthritis drive market growth. According to data from the World Health Organization in 2018, 70% of deaths worldwide are caused by diabetes, heart disease, stroke, chronic lung disease, and non-communicable diseases such as heart disease, stroke and cancer. In addition, the increase in the elderly population, the adoption of technologically advanced equipment, and the increase in health care expenditures provide a favorable background for market growth. In addition, due to their ease of use, portability, ergonomic design and visual monitoring functions, they are conducive to the potential growth of the market; however, the high cost of drug infusion systems, the shortage of skilled labor, and strict government regulations for product approval, etc. Factors are expected to limit market growth during the forecast period.
Research methods :
Kenneth research conducted the research by industry experts who provide insights into industry structure, market segmentation, evaluation, competitive landscape (CL), penetration rates, and emerging trends. In addition to initial interviews (~80%) and secondary research (~20%), your analysis is also based on your years of professional experience in your respective industry. Our analysts also predict market trends in the next five to ten years by analyzing historical trends and current market conditions. In addition, based on primary aND secondary research, research and estimate the changing trends of geographic market segments and categories.
Primary research Extensive primary research is conducted to gain a deeper understanding of market and industry performance. In this particular report, we conducted a preliminary survey (interview) of key executives (Vice Presidents, CEOs, Marketing Directors, Business Development Managers, etc.) of the major players active in the market. In addition to analyzing current and historical trends, our analysts also predict the market trend in the next five to ten years. Commercial research on the world drug infusion system market. It is also used to obtain key information about major players, market rankings, and segmentation based on industry trends, geographic markets, and market-related developments and prospects. In this study, analysts compiled information from various reliable sources, such as annual reports, SEC documents, magazines, white papers, company documents, company websites, international organizations of chemical manufacturers, and some paid databases.
Segmentation:
The global market for pharmaceutical infusion systems is segmented by product type, administration method, application, and end user. The drug infusion system market is subdivided into flexible infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia pumps (PCA), insulin pumps, and implantable infusion systems according to product types. According to the application, the market is divided into tumor/chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, etc.
The mode of administration is further subdivided into intravenous, subcutaneous, arterial, epidural and so on. On the basis of end users, the market is divided into hospitals, outpatient surgery centers, and diagnostic centers. Based on this region, the global market for medical infusion systems is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
America is divided into North America and South America. North America is further subdivided into the United States and Canada. The European region is divided into two parts, namely Western Europe and Eastern Europe. Western Europe is further divided into Germany, Italy, France, the United Kingdom, Spain and other parts of Western Europe. The Asia-Pacific region is subdivided into Japan, China, India, Australia, South Korea and other regions in the Asia-Pacific region. The Middle East and Africa region is subdivided into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and other regions in the Middle East and Africa.
Global drug infusion system market:
A major player Medtronicarcomed AG Braun Melsungen AG BaxterBecton Dickinson and CompanyDebiotech S.A. Fresenius SE & Co. KGaA Halyard Health, Inc ICU Medical Inc Iradimed Corporation Insulet Corporation Terumo Corporation Smiths Group plc Tandem Diabetes Care MOOG INC. Others
World Health Organization, Heart Disease and Stroke Statistics in 2018, Organization for Economic Cooperation and Development, Asian Diabetes Prevention Initiative market drug infusion based on North America Mainly to the growing chronic disease area.
According to statistics on heart disease and stroke in 2018, 836,546 people died of cardiovascular disease in the United States. Such a high incidence of cardiovascular disease has promoted the growth of the market in this region. It is estimated that Europe ranks second in the world market for drug infusion systems. The increasing prevalence of chronic diseases, increasing healthcare expenditures and healthcare activities are driving the growth of this European market.
According to data from the Organization for Economic Cooperation and Development (OECD), in 2016, 550,000 working-age people in EU countries died of chronic diseases. Such a high prevalence of chronic diseases is expected to boost the market in this region.
The Asia-Pacific region is expected to become the fastest growing region in the global pharmaceutical infusion system market. Drug infusion systems are commonly used to deliver insulin into the patient. The increase in the prevalence of diabetes has affected the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world’s diabetes population lives in Asia. This has promoted the growth of the market in the region. Due to strict government policies and economic downturn, the Middle East and Africa have the smallest share of the global drug infusion system market. However, increasing investment by private market participants in the region can promote market growth.
Market segmentation and major market players:
global drug infusion system market, by product type elastomer infusion system disposable infusion system syringe infusion system peristaltic pump multi-channel pump patient controlled analgesia (PCA) pump insulin implantable infusion system global drugs Infusion system market, intravenous subcutaneous arterial epidural other global drug infusion system market managed by application method, according to end-user hospital outpatient surgery center diagnostic center others"
Related Reports
Proof of Quality & Reliability
